Obesity complicates heart failure treatment, Swedish data shows

Obese patients with weakened hearts respond differently to standard medications than non-obese patients, a major registry study finds. The discovery could reshape how doctors tailor heart failure drugs—a critical issue as obesity rates climb and heart disease remains the leading cause of death globally.

Originaltitel: Use of and association between heart failure pharmacological treatments and outcomes in obese versus non-obese patients with heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry